GO:0050211 procollagen galactosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050211 procollagen galactosyltransferase activity catalyzes the transfer of galactose from UDP-galactose to 5-hydroxylysine residues on procollagen, producing galactosyloxylysine and UDP.
• The reaction is one of the final steps in collagen post-translational modification and is required for proper collagen folding and basement membrane assembly.
• Two beta(1-O)galactosyltransferases, GLT25D1 (COLGALT1) and GLT25D2 (COLGALT2), initiate core glycosylation of collagen by adding galactose to hydroxylysine.
• Lysyl hydroxylase 3 (LH3, PLOD3) carries both lysyl hydroxylase and galactosyltransferase activities, coupling hydroxylysine formation to its subsequent glycosylation.
• Altered procollagen galactosyltransferase activity has been observed in fibrotic conditions such as scleroderma and carbon tetrachloride-induced liver fibrosis.
• Studying this activity requires a combination of enzyme assays, knockout/knock-in cell models, and glycoproteomics to link genotype to collagen glycosylation phenotypes.
Description
Procollagen galactosyltransferase activity (GO:0050211) is a molecular function that attaches galactose to hydroxylysine residues on procollagen, a critical modification for collagen stability and function. Collagen is the most abundant protein in mammals, and its biosynthesis involves a series of post-translational modifications, including hydroxylation and glycosylation, that occur before triple-helix formation. The galactosyltransferase step is one of the final modifications in this pathway, and its products influence collagen cross-linking, fibril assembly, and interactions with other extracellular matrix components. Researchers study this activity to understand connective tissue development, basement membrane formation, and the molecular basis of fibrotic diseases. The enzyme activity is primarily associated with the luminal side of the endoplasmic reticulum and is mediated by enzymes such as GLT25D1 and GLT25D2, which were identified as the core collagen galactosyltransferases. Because defects in collagen glycosylation can lead to structural abnormalities, this GO term is a focal point for investigations into extracellular matrix biology and related pathologies.
procollagen galactosyltransferase activity At A Glance
| GO ID | GO:0050211 |
|---|---|
| GO term | procollagen galactosyltransferase activity |
| Ontology | molecular_function |
| Synonym | collagen galactosyltransferase activity; collagen hydroxylysyl galactosyltransferase activity; hydroxylysine galactosyltransferase activity; UDPgalactose:5-hydroxylysine-collagen galactosyltransferase activity; UDP galactose-collagen galactosyltransferase activity; UDP-galactose:procollagen-5-hydroxy-L-lysine D-galactosyltransferase activity; UDPgalactose:procollagen-5-hydroxy-L-lysine D-galactosyltransferase activity; uridine diphosphogalactose-collagen galactosyltransferase activity |
| Major function | Transfer of galactose from UDP-galactose to 5-hydroxylysine residues on procollagen, forming galactosyloxylysine and UDP. |
| Reaction | UDP-galactose + procollagen 5-hydroxy-L-lysine = UDP + procollagen 5-(D-galactosyloxy)-L-lysine. |
| Cellular location | Endoplasmic reticulum lumen; mainly intramembranous microsomal enzymes. |
| Enzymes | GLT25D1 (COLGALT1), GLT25D2 (COLGALT2), and lysyl hydroxylase 3 (LH3, PLOD3). |
| Substrates | UDP-galactose and procollagen containing 5-hydroxylysine. |
| Related process | Collagen post-translational modification and basement membrane assembly. |
What Is GO:0050211?
Procollagen galactosyltransferase activity is defined as the catalysis of the reaction: UDP-galactose + procollagen 5-hydroxy-L-lysine = UDP + procollagen 5-(D-galactosyloxy)-L-lysine. In other words, it is the enzyme activity that transfers a galactose molecule from UDP-galactose to a specific hydroxylysine residue on procollagen, forming a galactosyl-hydroxylysine linkage and releasing UDP. This modification is part of the glycosylation of collagen, which occurs in the endoplasmic reticulum and contributes to the proper folding and secretion of collagen molecules.
Why Is procollagen galactosyltransferase activity Important in Cell Biology?
Procollagen galactosyltransferase activity is essential for the proper structure and function of collagen, the most abundant protein in the human body. This enzymatic step adds galactose to hydroxylysine residues, a modification that influences collagen cross-linking, fibril formation, and interactions with other extracellular matrix molecules. Disruptions in this activity have been linked to defective basement membranes and connective tissue disorders, and altered enzyme levels are observed in fibrotic diseases such as scleroderma and liver fibrosis. Understanding this activity provides insights into extracellular matrix biology, tissue development, and the pathogenesis of diseases involving collagen abnormalities.
• Required for proper collagen folding and basement membrane assembly.
• Influences collagen cross-linking and fibril stability.
• Enzyme activity is altered in systemic scleroderma fibroblasts.
• Changes in activity are observed in carbon tetrachloride-induced liver fibrosis.
• Enzymes are mainly intramembranous microsomal proteins, indicating a role in the secretory pathway.
• Activity is developmentally regulated during cartilage and bone formation.
• Regulation differs between normal and transformed cells.
• Enzymes are present in macrophages and mast cells, suggesting roles in inflammation.
• Defects can lead to structural abnormalities in connective tissues.
• Target for research in fibrosis and extracellular matrix disorders.
What Happens During procollagen galactosyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and attaches to the collagen protein at specific spots.
The galactosyltransferase enzymes recognize procollagen molecules that contain 5-hydroxylysine residues, which are generated by lysyl hydroxylase activity. The enzymes bind to these specific sites on the procollagen triple helix or its unfolded chains, positioning the hydroxylysine for galactose transfer.
Catalytic transfer of galactose
In simple terms: The enzyme moves a sugar molecule from one carrier to the collagen.
Using UDP-galactose as the donor substrate, the enzyme catalyzes the transfer of galactose to the hydroxyl group of 5-hydroxylysine on procollagen, forming a beta-galactosyl-hydroxylysine linkage and releasing UDP. This reaction is part of the core glycosylation of collagen and is mediated by enzymes such as GLT25D1 and GLT25D2.
Coordination with lysyl hydroxylase activity
In simple terms: The same enzyme or complex can both create the attachment site and add the sugar.
Lysyl hydroxylase 3 (LH3) possesses both lysyl hydroxylase and galactosyltransferase activities, allowing it to first hydroxylate lysine residues and then galactosylate them. This coupling ensures efficient modification of collagen and is essential for basement membrane formation.
Completion of collagen glycosylation
In simple terms: After galactose is added, the collagen is ready for further processing.
The galactosylation step is one of the final modifications before procollagen folding and secretion. The added galactose can be further extended by glucosyltransferase to form glucosyl-galactosyl-hydroxylysine, but the galactose addition itself is a prerequisite for subsequent modifications and proper collagen function.
Key Genes Involved in GO:0050211 procollagen galactosyltransferase activity
The following genes encode enzymes or proteins directly involved in procollagen galactosyltransferase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COLGALT1 (GLT25D1) | Beta(1-O)galactosyltransferase that initiates core glycosylation of collagen by adding galactose to hydroxylysine. | Knockout studies show loss of collagen galactosylation and defects in collagen secretion. |
| COLGALT2 (GLT25D2) | Beta(1-O)galactosyltransferase with similar activity to COLGALT1, contributing to collagen glycosylation. | Potential redundancy with COLGALT1; double knockout needed to fully abolish activity. |
| PLOD3 (LH3) | Multifunctional enzyme with lysyl hydroxylase and galactosyltransferase activities, essential for basement membranes. | Mutations cause connective tissue disorders; knockout leads to embryonic lethality. |
| PLOD1 | Lysyl hydroxylase 1, generates hydroxylysine substrates for galactosylation. | Defects cause Ehlers-Danlos syndrome type VI; affects substrate availability. |
| PLOD2 | Lysyl hydroxylase 2, hydroxylates lysine residues in collagen telopeptides. | Implicated in fibrosis and cancer; may influence glycosylation sites. |
| COL1A1 | Major fibrillar collagen; contains hydroxylysine residues that are galactosylated. | Mutations cause osteogenesis imperfecta; glycosylation changes affect phenotype. |
| COL1A2 | Type I collagen alpha-2 chain; substrate for galactosylation. | Studied in connective tissue disorders and fibrosis models. |
| COL4A1 | Basement membrane collagen; requires glycosylation for network assembly. | Knockout models show basement membrane defects. |
| COL4A2 | Basement membrane collagen; glycosylation affects secretion and assembly. | Mutations linked to porencephaly and hemorrhagic stroke. |
| COL6A1 | Microfibrillar collagen; contains hydroxylysine glycosylation sites. | Bethlem myopathy and Ullrich congenital muscular dystrophy. |
| COL6A2 | Microfibrillar collagen; glycosylation contributes to stability. | Muscular dystrophy research. |
| COL6A3 | Microfibrillar collagen; glycosylation affects fibril formation. | Congenital muscular dystrophy models. |
| COL3A1 | Type III collagen; glycosylation important for vascular integrity. | Ehlers-Danlos syndrome type IV. |
| COL5A1 | Type V collagen; regulates fibril nucleation; glycosylation sites present. | Classical Ehlers-Danlos syndrome. |
| COL5A2 | Type V collagen; glycosylation affects fibril assembly. | Connective tissue disorders. |
| COL2A1 | Type II collagen; major cartilage collagen with hydroxylysine glycosylation. | Chondrodysplasias and osteoarthritis. |
| COL9A1 | Type IX collagen; glycosylation contributes to cartilage matrix. | Multiple epiphyseal dysplasia. |
| COL11A1 | Type XI collagen; glycosylation affects cartilage fibrils. | Stickler syndrome and hearing loss. |
How Is procollagen galactosyltransferase activity Regulated?
Procollagen galactosyltransferase activity is regulated at multiple levels. The expression of the responsible enzymes, such as GLT25D1, GLT25D2, and LH3, is controlled transcriptionally and can be influenced by growth factors and cytokines. Enzyme activity is also dependent on the availability of substrates: hydroxylysine must be generated by lysyl hydroxylases, and UDP-galactose must be available in the endoplasmic reticulum lumen. Studies in transformed cells and during cartilage and bone development indicate that the activity is developmentally regulated and can be altered in disease states. In systemic scleroderma, fibroblasts show increased collagen synthesis and altered post-translational modifications, including galactosylation. Similarly, in carbon tetrachloride-induced liver fibrosis, enzyme markers of collagen synthesis, including galactosyltransferase, are elevated. These findings suggest that regulation occurs in response to extracellular signals and pathological conditions.
procollagen galactosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLOD3 | Connective tissue disorder with basement membrane defects | Knockout mice or patient-derived fibroblasts |
| COLGALT1 | Collagen glycosylation defects, potential fibrosis | CRISPR knockout in HEK293 or fibroblasts |
| COL1A1 | Osteogenesis imperfecta, fibrosis | Point mutation knock-in in osteoblasts |
| COL4A1 | Basement membrane abnormalities, stroke | Knock-in mouse models |
| PLOD1 | Ehlers-Danlos syndrome type VI | Patient fibroblasts and knockout models |
Connective tissue disorders and basement membrane defects
Mutations in PLOD3, which encodes lysyl hydroxylase 3 with galactosyltransferase activity, cause a rare connective tissue disorder characterized by basement membrane abnormalities, skin fragility, and skeletal defects. Loss of LH3 function in mice leads to embryonic lethality due to defective basement membranes, highlighting the essential role of this activity in development. Additionally, defects in collagen glycosylation can contribute to Ehlers-Danlos syndrome and osteogenesis imperfecta, where collagen structure and stability are compromised.
Fibrotic diseases
Altered procollagen galactosyltransferase activity has been observed in fibrotic conditions. In systemic scleroderma, cultured fibroblasts show increased collagen biosynthesis and changes in post-translational modifications, including galactosylation. In carbon tetrachloride-induced liver fibrosis, enzyme markers of collagen synthesis, such as galactosyltransferase, are elevated, and colchicine treatment modifies these changes. These findings suggest that dysregulation of collagen glycosylation contributes to fibrosis pathogenesis.
Cancer and transformed cells
Regulation of collagen post-translational modification differs between normal and transformed cells. Studies on transformed human and chick-embryo cells show altered levels of enzymes involved in collagen biosynthesis, including galactosyltransferase, which may affect tumor microenvironment and metastasis. The extracellular matrix remodeling in cancer often involves changes in collagen glycosylation, making this activity a potential target for research.
From procollagen galactosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of COLGALT1 abolish procollagen galactosyltransferase activity? | CRISPR knockout in HEK293 or fibroblasts |
| What is the effect of a specific point mutation in the catalytic domain of GLT25D1? | Point mutation knock-in via CRISPR |
| Can tagged COLGALT1 be used to track subcellular localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression of PLOD3 increase collagen galactosylation? | Overexpression cell lines |
| What is the role of COLGALT2 in compensating for COLGALT1 loss? | Double knockout models |
| How does altered glycosylation affect collagen secretion? | Knockout and rescue with wild-type or mutant enzyme |
How to Study the procollagen galactosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay with UDP-[3H]galactose | Galactose transfer to acceptor | Kinetic studies and inhibitor testing |
| LC-MS/MS glycoproteomics | Site-specific glycosylation of collagen | Mapping galactosylated hydroxylysine residues |
| CRISPR knockout screening | Genes required for activity | Identifying COLGALT1/2 and other factors |
| Western blot with anti-galactosyl-hydroxylysine antibody | Overall collagen galactosylation level | Validating knockout phenotypes |
| Immunofluorescence | Subcellular localization of enzymes | Confirming ER localization |
| qRT-PCR | mRNA expression of enzymes | Assessing transcriptional regulation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying enzyme complexes |
| Pulse-chase metabolic labeling | Collagen secretion and processing | Linking glycosylation to secretion |
Enzyme activity assays
Procollagen galactosyltransferase activity can be measured using radioactive or fluorescently labeled UDP-galactose and acceptor substrates such as hydroxylysine-containing peptides or procollagen. The transfer of galactose is quantified by separating products via chromatography or using coupled enzyme assays. These assays are used to assess enzyme kinetics, substrate specificity, and the effects of mutations.
Glycoproteomics and mass spectrometry
Mass spectrometry-based glycoproteomics allows site-specific identification and quantification of galactosyl-hydroxylysine on collagen. This method is used to confirm changes in glycosylation patterns in knockout or mutant cells and to map the exact residues modified by the enzymes.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for procollagen galactosyltransferase activity. Cells are subjected to selection based on collagen glycosylation status, and enriched sgRNAs reveal candidate genes such as COLGALT1 and COLGALT2.
Imaging and subcellular localization
Fluorescence microscopy of tagged enzymes (e.g., GFP-COLGALT1) reveals their localization to the endoplasmic reticulum and their co-localization with collagen. This helps confirm the compartment where galactosylation occurs.
How CRISPR Can Be Used to Study GO:0050211 procollagen galactosyltransferase activity
Knockout
CRISPR knockout of COLGALT1 or COLGALT2 in cell lines such as HEK293 or fibroblasts can abolish or reduce procollagen galactosyltransferase activity, leading to under-glycosylated collagen. These models are used to study the consequences of loss of glycosylation on collagen secretion, fibril formation, and basement membrane assembly. Double knockout of both genes is often necessary to fully eliminate activity due to redundancy.
Point Mutation
Introducing specific point mutations in the catalytic domain of COLGALT1 or PLOD3 via CRISPR can dissect the contribution of individual residues to galactosyltransferase activity. Such models help distinguish between lysyl hydroxylase and galactosyltransferase functions of multifunctional enzymes like LH3.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) into the endogenous COLGALT1 locus allows tracking of enzyme expression, localization, and interaction partners in a physiological context. This approach avoids artifacts from overexpression.
Overexpression
Overexpression of COLGALT1, COLGALT2, or PLOD3 in cell lines can increase procollagen galactosyltransferase activity and collagen glycosylation, providing a gain-of-function system to study downstream effects on extracellular matrix properties and cell behavior.
How EDITGENE Supports procollagen galactosyltransferase activity Research
Researchers studying procollagen galactosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in collagen glycosylation, how specific mutations affect enzyme function, and what the downstream consequences are for extracellular matrix biology. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for procollagen galactosyltransferase activity research.
Frequently Asked Questions About procollagen galactosyltransferase activity
What is procollagen galactosyltransferase activity?
It is the enzyme activity that transfers galactose from UDP-galactose to 5-hydroxylysine residues on procollagen, forming galactosyloxylysine and UDP. This modification is part of collagen post-translational processing.
What genes are involved in procollagen galactosyltransferase activity?
The main genes are COLGALT1 (GLT25D1) and COLGALT2 (GLT25D2), which encode beta(1-O)galactosyltransferases, and PLOD3 (LH3), which has both lysyl hydroxylase and galactosyltransferase activities.
What is the GO ID for procollagen galactosyltransferase activity?
The Gene Ontology ID is GO:0050211, under the molecular_function aspect.
Where does procollagen galactosyltransferase activity occur in the cell?
It occurs primarily in the lumen of the endoplasmic reticulum, as the enzymes are intramembranous microsomal proteins.
What diseases are associated with defects in procollagen galactosyltransferase activity?
Defects can lead to connective tissue disorders, basement membrane abnormalities, and have been observed in fibrotic diseases such as scleroderma and liver fibrosis.
How can I measure procollagen galactosyltransferase activity?
It can be measured using enzyme assays with radiolabeled UDP-galactose and collagen substrates, or by glycoproteomics to detect galactosyl-hydroxylysine on collagen.
What is the reaction catalyzed by procollagen galactosyltransferase?
UDP-galactose + procollagen 5-hydroxy-L-lysine = UDP + procollagen 5-(D-galactosyloxy)-L-lysine.
Is procollagen galactosyltransferase activity the same as collagen galactosyltransferase?
Yes, collagen galactosyltransferase activity is a synonym for procollagen galactosyltransferase activity (GO:0050211).
How is procollagen galactosyltransferase activity regulated?
It is regulated by expression of the enzymes, substrate availability (hydroxylysine and UDP-galactose), and can be altered in transformed cells and during development.
Can CRISPR be used to study procollagen galactosyltransferase activity?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect the function of genes like COLGALT1, COLGALT2, and PLOD3 in this activity.
Conclusion
Procollagen galactosyltransferase activity (GO:0050211) is a key enzymatic step in collagen biosynthesis, responsible for adding galactose to hydroxylysine residues and ensuring proper collagen structure and function. Its importance is underscored by its role in basement membrane assembly, connective tissue integrity, and its dysregulation in fibrotic diseases and cancer. Understanding this activity at the molecular level provides insights into extracellular matrix biology and opens avenues for therapeutic intervention. With advanced CRISPR tools and bioinformatics, researchers can now precisely manipulate the genes involved and uncover new details of this critical modification.
References
- 1. Ruotsalainen H et al.. 2006. Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes.. J Cell Sci 119(Pt 4):625-35 PMID: 16467571
- 2. Schegg B et al.. 2009. Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases.. Mol Cell Biol 29(4):943-52 PMID: 19075007
- 3. Myllylä R et al.. 1981. Regulation of collagen post-translational modification in transformed human and chick-embryo cells.. Biochem J 196(3):683-92 PMID: 6274318
- 4. Myllylä R et al.. 1981. Changes in intracellular enzymes of collagen biosynthesis during matrix-induced cartilage and bone development.. Biochim Biophys Acta 674(2):238-45 PMID: 6263351
- 5. Peltonen L et al.. 1985. Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts.. J Invest Dermatol 84(1):14-8 PMID: 2981273
- 6. Bolarin DM et al.. 1987. Enzyme markers of collagen synthesis in carbon tetrachloride-induced fibrosis and during colchicine modification of CCl4-induced liver injury.. Exp Mol Pathol 46(2):145-52 PMID: 3030797
- 7. Blumenkrantz N et al.. 1984. Characterization of collagen hydroxylysyl glycosyltransferases as mainly intramembranous microsomal enzymes.. J Biol Chem 259(2):854-9 PMID: 6229534
- 8. Myllylä R et al.. 1979. Studies on enzymes of collagen biosynthesis and the synthesis of hydroxyproline in macrophages and mast cells.. Biochem J 182(2):311-6 PMID: 228650
